Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients

The systemic inflammation response index (SIRI) is a useful tool for predicting prognosis in some types of cancer. In this retrospective study, we evaluated the efficacy of SIRI in predicting overall survival in hepatocellular carcinoma (HCC) patients following local or systemic therapy. A cutoff va...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Litao, Yu, Shulin, Zhuang, Liping, Wang, Peng, Shen, Yehua, Lin, Junhua, Meng, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471025/
https://www.ncbi.nlm.nih.gov/pubmed/28430597
http://dx.doi.org/10.18632/oncotarget.16865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471025/
https://www.ncbi.nlm.nih.gov/pubmed/28430597
http://dx.doi.org/10.18632/oncotarget.16865

Ejemplares similares